(Q73104302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

main subject

United States of America

1 reference

Avery RK

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Adal KA

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Longworth DL

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Bolwell BJ

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

763-767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11042658%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702608

1 November 2019

exact match

0 references

cites work

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Strategies for the prevention of cytomegalovirus disease after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegalovirus prophylaxis and treatment following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegalovirus and marrow function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021

Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702608

7 January 2021